Blood Processing: Component Separation, Storage, and Clinical Applications
Blood processing transforms whole blood donations into specialized components, enabling targeted therapy and efficient resource utilization. One donation can help multiple patients.
Collection & Initial Processing
- Phlebotomy: 450–500 mL whole blood + anticoagulant (CPD, CP2D, CPDA-1) into primary bag with satellite bags
- Filtration: Leukoreduction (prestorage) — removes >99.9% WBCs → ↓febrile reactions, HLA alloimmunization, CMV transmission, immunomodulation
- Centrifugation ("hard spin"): Separates red cells (bottom) from platelet-rich plasma (top)
- Second spin ("soft spin"): PRP → platelet concentrate (bottom) + plasma (top)
Major Components & Specifications
| Component | Volume | Storage | Shelf Life | Key Indications |
|---|---|---|---|---|
| Red Blood Cells (RBC) | ~250–350 mL (Hct 55–65%) | 1–6°C | 42 days (CPDA-1) | Anemia, hemorrhage, exchange transfusion |
| Fresh Frozen Plasma (FFP) | ~200–250 mL | ≤-18°C | 12 months (≤-18°C) | Coagulopathy, massive transfusion, TTP |
| Platelets (apheresis or pooled 4–6) | ~200–300 mL | 20–24°C, agitation | 5–7 days | Thrombocytopenia, platelet dysfunction |
| Cryoprecipitate | ~15–20 mL (from 1 FFP) | ≤-18°C | 12 months | Fibrinogen deficiency, vWD, DIC |
| Cryo-poor plasma | Remaining plasma | ≤-18°C | 12 months | Volume, other factors |
